Goldfinch Biopharma
Latest round
- Series B
Last raised
- Jun 2020
Total raised
- $126M
Investors
- 10
About Goldfinch Biopharma
Goldfinch Biopharma Inc. is a biopharmaceutical company focused on advancing transformative therapies for kidney diseases.Founded in 2016 in Cambridge, US, Goldfinch Biopharma Inc. specializes in developing treatments for kidney diseases.Goldfinch Biopharma Inc. offers a range of biopharmaceutical products aimed at treating kidney diseases. Their focus is on leveraging genetic insights to develop targeted therapies that can potentially improve patient outcomes.The company's revenue model is based on strategic partnerships and collaborations with healthcare providers and research institutions.Goldfinch Biopharma Inc. The company is targeting expansion into new markets, specifically in Europe and Asia, with plans to initiate these efforts by the end of 2023. Upcoming products are being designed to enhance treatment options and are expected to be launched in the next 18-24 months.
Who invested in Goldfinch Biopharma
10 investors across 2 rounds
See all investors in Goldfinch Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Goldfinch Biopharma
Who invested in Goldfinch Biopharma?
Goldfinch Biopharma has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Goldfinch Biopharma raised?
Goldfinch Biopharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Goldfinch Biopharma last raise money?
Goldfinch Biopharma's most recent round on record is a Series B, in Jun 2020.
What does Goldfinch Biopharma do?
Goldfinch Biopharma is a biotechnology company.
Where is Goldfinch Biopharma headquartered?
Goldfinch Biopharma is headquartered in Cambridge, US.
Which VCs invest in companies like Goldfinch Biopharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Goldfinch Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Goldfinch Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.